Healthcare Triangle is trading at $5.53, +11.02% in pre-market on November 3, following its November 2 announcement of a potential $20–45 million Indonesia opportunity pipeline.

  • A market-movers report explicitly linked the pre-market rise to the announcement.
  • The opportunities are uncontracted, at different sales stages and are not revenue guidance; conversion depends on agreements, successful pilots, approvals and local delivery.
  • Shares closed at $4.98 on November 2, after declining from the October 26 close of $6.84.